Soybean oil contracts fell from their highest in three-and-a-half years, following a slump in crude after President Donald Trump said he would pause US-led efforts to guide ships through the Strait of Hormuz. Trump cited “great progress” toward a peace deal between Washington and Tehran and confirmed that there would be a halt on the two-day-old push to escort ships through the important trade rou...
Soybean oil contracts fell from their highest in three-and-a-half years, following a slump in crude after President Donald Trump said he would pause US-led efforts to guide ships through the Strait of Hormuz. Trump cited “great progress” toward a peace deal between Washington and Tehran and confirmed that there would be a halt on the two-day-old push to escort ships through the important trade route. Crude oil fell on the prospect of a resolution to the crisis in the Middle East, with Brent dropping for a second day and trading near $108 a barrel. Soybean oil, a key biofuel input, tends to track crude prices closely, and the recent war-driven spike in oil and gas costs has boosted demand for alternative energy sources. After hitting the highest level since November 2022 on Tuesday, most-active soybean oil futures declined by as much as 0.9% on Wednesday. However, strong global demand for biofuels meant that soy oil didn’t see the same magnitude of fall as crude, said Joe Davis, a director at brokerage Futures International in Chicago. Brent futures dropped as much as 2.1% before trimming some losses. “Vegoils globally are bullish,” said Davis, highlighting robust demand in the US, where higher biofuel quotas have been introduced to boost domestic use. He said soon after soybean oil prices fell, buyers immediately began to swoop in to buy the dip, a sign of bullish market sentiment. Soybean oil was down 0.8% to 76.25 cents a pound at 11.50 a.m. in Singapore Soybeans were unchanged, while corn fell 0.5% to $4.7750 a bushel Wheat was 0.5% lower to $6.2450 a bushel
Donny DBM/iStock via Getty Images The following segment was excerpted from the Aristotle Global Equity Advisory Q1 2026 Commentary. Relative Contributors Relative Detractors TotalEnergies ( TTE ) MonotaRO ( MONOY ) Cameco ( CCJ ) Nemetschek ( NEMTF ) FirstCash ( FCFS ) Capital One Financial ( COF ) Otsuka Holdings ( OTSKY ) Sony ( SONY ) Oshkosh ( OSK ) Qualcomm ( QCOM ) Click to enlarge Relative ...
Donny DBM/iStock via Getty Images The following segment was excerpted from the Aristotle Global Equity Advisory Q1 2026 Commentary. Relative Contributors Relative Detractors TotalEnergies ( TTE ) MonotaRO ( MONOY ) Cameco ( CCJ ) Nemetschek ( NEMTF ) FirstCash ( FCFS ) Capital One Financial ( COF ) Otsuka Holdings ( OTSKY ) Sony ( SONY ) Oshkosh ( OSK ) Qualcomm ( QCOM ) Click to enlarge Relative contributors and detractors are based on attribution total effect and exclude benchmark securities not held in the portfolio. Click to enlarge MonotaRO, the Japanese business-to-business (B2B) e-commerce platform, was the largest detractor during the quarter. While results remained strong, the stock price was pressured by softer order trends in the enterprise business and a moderation in new customer additions following a period of unusually strong growth. Sentiment was also pressured by the company's exposure to small and medium-sized enterprises in manufacturing and construction, cyclical and cost-sensitive end markets, particularly amid elevated input costs. Despite these near-term headwinds, profitability remained stable, with margin expansion supported by procurement efficiencies, reduced promotional discounting and higher royalty income. Enterprise business also grew more than 20% through newly connected corporations, expanding to approximately one-third of sales, highlighting its increasing importance within the business and reinforcing a key catalyst we originally identified. Management also announced a ¥10 billion share repurchase program, supporting shareholder returns and reflecting continued discipline in capital allocation. Over the longer term, we believe MonotaRO remains well-positioned to continue gaining share in Japan's fragmented and underpenetrated MRO market. The company's broad assortment, operating scale and growing enterprise presence, in our view, support a business that is becoming more embedded in customer procurement workflows over time. Qualcomm...
(RTTNews) - Samsung Epis Holdings Co Ltd (0126Z0.KS), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, reported first quarter net income attributable to shareholders of parent company of 99.5 billion Korean won. Net income from continuing op
(RTTNews) - Samsung Epis Holdings Co Ltd (0126Z0.KS), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, reported first quarter net income attributable to shareholders of parent company of 99.5 billion Korean won. Net income from continuing op
metamorworks/iStock via Getty Images Avalo Therapeutics ( AVTX ) late Tuesday priced an underwritten public offering of 19.73 million shares of common stock, along with pre-funded warrants for 1.4 million shares issued to certain investors in lieu of stock. The shares of common stock are being sold at a public offering price of $17.75 per share, and the pre-funded warrants are being sold at a publ...
metamorworks/iStock via Getty Images Avalo Therapeutics ( AVTX ) late Tuesday priced an underwritten public offering of 19.73 million shares of common stock, along with pre-funded warrants for 1.4 million shares issued to certain investors in lieu of stock. The shares of common stock are being sold at a public offering price of $17.75 per share, and the pre-funded warrants are being sold at a public offering price of $17.749 per pre-funded warrant. The gross proceeds to Avalo from the offering, expected to close on May 7, are estimated to be approximately $375M. Avalo Therapeutics ( AVTX ) shares rose 48.5% in extended trading. More on Avalo Therapeutics Seeking Alpha’s Quant Rating on Avalo Therapeutics Historical earnings data for Avalo Therapeutics Financial information for Avalo Therapeutics
This story has been made freely available as a public service to our readers. Please consider supporting SCMP’s journalism by subscribing. All eyes are on the Housing Bureau’s Independent Checking Unit (ICU), whose officers are scheduled to testify before a judge-led panel on Wednesday about their role in Hong Kong’s Tai Po blaze. Senior maintenance surveyor Andy Ku Siu-ping will be the only witne...
This story has been made freely available as a public service to our readers. Please consider supporting SCMP’s journalism by subscribing. All eyes are on the Housing Bureau’s Independent Checking Unit (ICU), whose officers are scheduled to testify before a judge-led panel on Wednesday about their role in Hong Kong’s Tai Po blaze. Senior maintenance surveyor Andy Ku Siu-ping will be the only witness giving live evidence in the first of three sessions of the fourth round of evidential...
Earnings Call Insights: Marqeta (MQ) Q1 2026 Management View “Our first quarter results demonstrate the continued momentum of our business. Gross profit grew 19%, which was fueled by 33% TPV growth... adjusted EBITDA grew to $33 million, achieving a 20% margin... we delivered GAAP profitability this quarter. The $8 million of net income is a testament to our strong growth, operating leverage, and ...
Earnings Call Insights: Marqeta (MQ) Q1 2026 Management View “Our first quarter results demonstrate the continued momentum of our business. Gross profit grew 19%, which was fueled by 33% TPV growth... adjusted EBITDA grew to $33 million, achieving a 20% margin... we delivered GAAP profitability this quarter. The $8 million of net income is a testament to our strong growth, operating leverage, and disciplined execution.” (CEO Mike Milotich) “Already 12 of our top 15 customers utilize Marqeta in more than one country, and 6 of those 12 are in at least 5 countries...” (CEO Milotich) “An emerging use case that will be multinational from the start is stablecoin-backed card programs, leveraging stablecoin settlement through our bank and network partners.” (CEO Milotich) “This quarter, we signed a customer... [that] will migrate their existing portfolio to Marqeta, and we are one of the early adopters of the issuer-managed Mastercard One credential to support this new customer.” (CEO Milotich) “Both net revenue and gross profit grew 19% on a year-over-year basis, driven by TPV growth of 33%... adjusted EBITDA growth of 66%... we achieved GAAP profitability in the quarter with net income of $8 million.” (CFO Patti Kangwankij) “In Q1, we repurchased 9.4 million shares at an average price of $4.16... As of March 31, we had over $52 million remaining on our latest buyback authorization.” (CFO Kangwankij) “The reverse stock split would reduce Marqeta's common stock at a ratio of 1:4... We believe a lower share count will provide a clearer reflection of changes in our per share performance...” (CFO Kangwankij) Outlook “We expect both Q2 net revenue and gross profit to grow between 14% to 16%.” (CFO Kangwankij) “Q2 adjusted operating expenses are expected to grow in the high teens... Q2 adjusted EBITDA growth is expected to be 10% to 12%... and we expect to be at breakeven on a GAAP net income basis in Q2.” (CFO Kangwankij) “We expect net revenue growth of 12% to 14% and gross pr...